Antiviral Activity of Zinc Finger Antiviral Protein (ZAP) in Different Virus Families

The CCCH-type zinc finger antiviral protein (ZAP) in humans, specifically isoforms ZAP-L and ZAP-S, is a crucial component of the cell’s intrinsic immune response. ZAP acts as a post-transcriptional RNA restriction factor, exhibiting its activity during infections caused by retroviruses and alphavir...

Full description

Bibliographic Details
Main Authors: Kívia Queiroz de Andrade, Claudio Cesar Cirne-Santos
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Pathogens
Subjects:
Online Access:https://www.mdpi.com/2076-0817/12/12/1461
_version_ 1797379712369033216
author Kívia Queiroz de Andrade
Claudio Cesar Cirne-Santos
author_facet Kívia Queiroz de Andrade
Claudio Cesar Cirne-Santos
author_sort Kívia Queiroz de Andrade
collection DOAJ
description The CCCH-type zinc finger antiviral protein (ZAP) in humans, specifically isoforms ZAP-L and ZAP-S, is a crucial component of the cell’s intrinsic immune response. ZAP acts as a post-transcriptional RNA restriction factor, exhibiting its activity during infections caused by retroviruses and alphaviruses. Its function involves binding to CpG (cytosine-phosphate-guanine) dinucleotide sequences present in viral RNA, thereby directing it towards degradation. Since vertebrate cells have a suppressed frequency of CpG dinucleotides, ZAP is capable of distinguishing foreign genetic elements. The expression of ZAP leads to the reduction of viral replication and impedes the assembly of new virus particles. However, the specific mechanisms underlying these effects have yet to be fully understood. Several questions regarding ZAP’s mechanism of action remain unanswered, including the impact of CpG dinucleotide quantity on ZAP’s activity, whether this sequence is solely required for the binding between ZAP and viral RNA, and whether the recruitment of cofactors is dependent on cell type, among others. This review aims to integrate the findings from studies that elucidate ZAP’s antiviral role in various viral infections, discuss gaps that need to be filled through further studies, and shed light on new potential targets for therapeutic intervention.
first_indexed 2024-03-08T20:26:57Z
format Article
id doaj.art-623cb4fa862e45adb62395c574c12815
institution Directory Open Access Journal
issn 2076-0817
language English
last_indexed 2024-03-08T20:26:57Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Pathogens
spelling doaj.art-623cb4fa862e45adb62395c574c128152023-12-22T14:31:05ZengMDPI AGPathogens2076-08172023-12-011212146110.3390/pathogens12121461Antiviral Activity of Zinc Finger Antiviral Protein (ZAP) in Different Virus FamiliesKívia Queiroz de Andrade0Claudio Cesar Cirne-Santos1Laboratory of Immunology of Infectious Disease, Immunology Department, Institute of Biomedical Sciences, University of São Paulo, São Paulo 05508-000, SP, BrazilLaboratory of Molecular Virology and Marine Biotechnology, Department of Cellular and Molecular Biology, Institute of Biology, Federal Fluminense University, Niterói 24020-150, RJ, BrazilThe CCCH-type zinc finger antiviral protein (ZAP) in humans, specifically isoforms ZAP-L and ZAP-S, is a crucial component of the cell’s intrinsic immune response. ZAP acts as a post-transcriptional RNA restriction factor, exhibiting its activity during infections caused by retroviruses and alphaviruses. Its function involves binding to CpG (cytosine-phosphate-guanine) dinucleotide sequences present in viral RNA, thereby directing it towards degradation. Since vertebrate cells have a suppressed frequency of CpG dinucleotides, ZAP is capable of distinguishing foreign genetic elements. The expression of ZAP leads to the reduction of viral replication and impedes the assembly of new virus particles. However, the specific mechanisms underlying these effects have yet to be fully understood. Several questions regarding ZAP’s mechanism of action remain unanswered, including the impact of CpG dinucleotide quantity on ZAP’s activity, whether this sequence is solely required for the binding between ZAP and viral RNA, and whether the recruitment of cofactors is dependent on cell type, among others. This review aims to integrate the findings from studies that elucidate ZAP’s antiviral role in various viral infections, discuss gaps that need to be filled through further studies, and shed light on new potential targets for therapeutic intervention.https://www.mdpi.com/2076-0817/12/12/1461ZAP proteinPARP-13antiviral activity
spellingShingle Kívia Queiroz de Andrade
Claudio Cesar Cirne-Santos
Antiviral Activity of Zinc Finger Antiviral Protein (ZAP) in Different Virus Families
Pathogens
ZAP protein
PARP-13
antiviral activity
title Antiviral Activity of Zinc Finger Antiviral Protein (ZAP) in Different Virus Families
title_full Antiviral Activity of Zinc Finger Antiviral Protein (ZAP) in Different Virus Families
title_fullStr Antiviral Activity of Zinc Finger Antiviral Protein (ZAP) in Different Virus Families
title_full_unstemmed Antiviral Activity of Zinc Finger Antiviral Protein (ZAP) in Different Virus Families
title_short Antiviral Activity of Zinc Finger Antiviral Protein (ZAP) in Different Virus Families
title_sort antiviral activity of zinc finger antiviral protein zap in different virus families
topic ZAP protein
PARP-13
antiviral activity
url https://www.mdpi.com/2076-0817/12/12/1461
work_keys_str_mv AT kiviaqueirozdeandrade antiviralactivityofzincfingerantiviralproteinzapindifferentvirusfamilies
AT claudiocesarcirnesantos antiviralactivityofzincfingerantiviralproteinzapindifferentvirusfamilies